•
Mar 31, 2022

TG Therapeutics Q1 2022 Earnings Report

Total Revenue
$2.02M
Previous year: $793K
+154.2%
EPS
-$0.51
Previous year: -$0.69
-26.1%
R&D Expense
$48M
Previous year: $63.1M
-23.9%
SG&A Expense
$20.6M
Previous year: $26.8M
-23.0%
Gross Profit
$2.02M
Previous year: $654K
+208.3%
Cash and Equivalents
$186M
Previous year: $524M
-64.6%
Free Cash Flow
-$68.7M
Previous year: -$81.4M
-15.6%
Total Assets
$303M
Previous year: $549M
-44.8%

TG Therapeutics

TG Therapeutics